4//SEC Filing
Akinsanya Karen 4
Accession 0001628280-24-008959
CIK 0001490978other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:44 PM ET
Size
5.5 KB
Accession
0001628280-24-008959
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Stock Option (right to buy)
2024-03-04+120,000→ 120,000 totalExercise: $25.24Exp: 2034-03-04→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797672
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:44 PM ET
- Size
- 5.5 KB